Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT01267513
Other study ID # Oxytone/Lifebeam Monitor
Secondary ID MMC202/2010
Status Recruiting
Phase N/A
First received December 27, 2010
Last updated March 16, 2012
Start date April 2011
Est. completion date May 2012

Study information

Verified date March 2012
Source Meir Medical Center
Contact Louis Shenkman, AB, MD
Phone +972-544-876600
Email louissh@clalit.org.il
Is FDA regulated No
Health authority Israel: Ethics Commission
Study type Observational

Clinical Trial Summary

Ambulatory monitoring of physiological variables is important in following the health status of individuals in non-hospital controlled situations. The investigators are developing a non-invasive sensor based on dynamic light scattering that is able to measure pulse, blood flow and coagulability. Oxygen saturation can also be detected with minor modification of the apparatus. The investigators plan to validate the investigators sensor by applying it to patients in the intensive care unit, or to patients undergoing cardiac stress tests. The results of the investigators sensor will not be utilized for any therapeutic decisions, but will be collected for later comparison with conventional monitoring of pulse and oxygenation with standard monitors. The monitor is worn like a wrist watch, and will collect data into a small data storage disc for later analysis.


Description:

Subjects to be studied will be either individuals undergoing routine cardiac stress tests, or patients admitted to the pulmonary ward of Meir Hospital who are being monitored in conventional manner. Normal volunteers will also be tested, under the following conditions: at rest, while running, while performing calisthenics, and while crawling on the ground. If non-inferiority of the new sensor is established compared to the standard clinically used sensors, then additional studies will be performed on acutely ill patients, such as patients admitted with multi-trauma.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date May 2012
Est. primary completion date May 2012
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Patients who are able to sign informed consent.

- Patients undergoing standard cardiac stress tests who are able to sign informed consent.

- Patients with pulmonary disease who are being monitored in a routine manner who are will ing to sign informed consent.

Exclusion Criteria:

- Children

- Patients unable or unwilling to give consent

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Non Invasive Test of Pulse and Oxygen Saturation

Locations

Country Name City State
Israel Meir Medical Center Kfar Saba

Sponsors (2)

Lead Sponsor Collaborator
Meir Medical Center Tel Aviv University

Country where clinical trial is conducted

Israel, 

References & Publications (1)

Shitrit D, Rusanov V, Peled N, Amital A, Fuks L, Kramer MR. The 15-step oximetry test: a reliable tool to identify candidates for lung transplantation among patients with idiopathic pulmonary fibrosis. J Heart Lung Transplant. 2009 Apr;28(4):328-33. doi: 10.1016/j.healun.2008.12.019. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of oxygen saturation and pulse rate between our sensor and conventional sensors We wish to determine non-inferiority of our new sensor compared to current non-ambulatory sensors. 0ne year No